<?xml version='1.0' encoding='utf-8'?>
<document id="30158052"><sentence text="Identification of Mechanism and Pathway of the Interaction between the African Traditional Medicine, Sutherlandia Frutescens, and the Antiretroviral Protease Inhibitor, Atazanavir, in Human Subjects Using Population Pharmacokinetic (PK) Analysis."><entity charOffset="169-179" id="DDI-PubMed.30158052.s1.e0" text="Atazanavir" /></sentence><sentence text="Although the use of the indigenous Southern African plant, Sutherlandia frutescens (SF) for the treatment of HIV/AIDS has previously been described, the risk which it may pose to the safety and efficacy of ARVs and the potential mechanisms which underlie such effects may have clinical significance and relevance" /><sentence text=" The protease inhibitor (PI), atazanavir (ATV) is a substrate of the efflux transporter, P-gp which modulates absorption in the small intestine, as well as CYP3A4 and CYP3A5enzymes which facilitate metabolism in the small intestine and liver"><entity charOffset="30-40" id="DDI-PubMed.30158052.s3.e0" text="atazanavir" /></sentence><sentence text=" The objective of this study was to investigate the effect of SF on the pharmacokinetics (PK) of atazanavir (ATV) and to use a population PK analysis to fit and explain plasma concentration vs"><entity charOffset="62-64" id="DDI-PubMed.30158052.s4.e0" text="SF" /><entity charOffset="97-107" id="DDI-PubMed.30158052.s4.e1" text="atazanavir" /><pair ddi="false" e1="DDI-PubMed.30158052.s4.e0" e2="DDI-PubMed.30158052.s4.e0" /><pair ddi="false" e1="DDI-PubMed.30158052.s4.e0" e2="DDI-PubMed.30158052.s4.e1" /></sentence><sentence text=" time profiles of ATV generated in a previously conducted study in healthy male subjects in order to understand and postulate on the potential mechanism(s) of the drug-drug interaction" /><sentence text=" The population PK Compartmental Analysis of ATV before and after a two-week regimen of Phyto Nova Sutherlandia SU1 tablets which contain SF plant material indicated that a two compartment model with a dual absorption mechanism best explained the data"><entity charOffset="138-147" id="DDI-PubMed.30158052.s6.e0" text="SF" /></sentence><sentence text=" The dual absorption mechanism is hypothesized to reflect &quot;passive&quot; (first-order, Ka parameter) and &quot;active&quot; (zero-order, K0 parameter) absorption processes" /><sentence text=" The model suggested that the mechanism by which SF reduced the overall bioavailability of ATV may be modulated via the inhibition of the &quot;active&quot; absorption process"><entity charOffset="49-50" id="DDI-PubMed.30158052.s8.e0" text="SF" /></sentence><sentence text=" This study has highlighted the utility of population PK analyses in postulating probable mechanism(s) whereby an ATM or a herbal medicine interacts with an allopathic drug" /><sentence text="" /></document>